| Prevalence and risk factors of hypertension in adults in an Urban Slum, Tirupati, AP SS Reddy, GR Prabhu Indian Journal of community medicine 30 (3), 84-86, 2005 | 121 | 2005 |
| Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL) SR Sanikommu, MJ Clemente, P Chomczynski, MG Afable, A Jerez, ... Leukemia & lymphoma 59 (2), 416-422, 2018 | 102 | 2018 |
| Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation OR Copelan, SR Sanikommu, JS Trivedi, C Butler, J Ai, BK Ragon, ... Biology of Blood and Marrow Transplantation 25 (4), 785-790, 2019 | 56 | 2019 |
| Financial toxicity intervention improves outcomes in patients with hematologic malignancy TG Knight, M Aguiar, M Robinson, A Morse, T Chen, R Bose, J Ai, ... JCO Oncology Practice 18 (9), e1494-e1504, 2022 | 34 | 2022 |
| Genomics of therapy-related myeloid neoplasms T Kuzmanovic, BJ Patel, SR Sanikommu, Y Nagata, H Awada, CM Kerr, ... Haematologica 105 (3), e98, 2020 | 34 | 2020 |
| The complexity of interpreting genomic data in patients with acute myeloid leukemia A Nazha, A Zarzour, K Al-Issa, T Radivoyevitch, HE Carraway, CM Hirsch, ... Blood Cancer Journal 6 (12), e510-e510, 2016 | 24 | 2016 |
| Pain management trend of vaso-occulsive crisis (VOC) at a community hospital emergency department (ED) for patients with sickle cell disease S Inoue, I Khan, R Mushtaq, SR Sanikommu, C Mbeumo, J LaChance, ... Annals of hematology 95, 221-225, 2016 | 18 | 2016 |
| Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions S Thota, BJ Patel, M Sadaps, S Balasubramanian, S Sanikommu, ... British journal of haematology 183 (1), 133, 2018 | 13 | 2018 |
| Use of buprenorphine/naloxone in ameliorating acute care utilization and chronic opioid use in adults with sickle cell disease P Veeramreddy, J Arnall, R Crawford, JT Symanowski, R Olaosebikan, ... Blood 134, 790, 2019 | 12 | 2019 |
| Evorpacept (ALX148), a CD47-blocking myeloid checkpoint inhibitor, in combination with azacitidine: a phase 1/2 study in patients with myelodysplastic syndrome (ASPEN-02) G Garcia-Manero, HP Erba, SR Sanikommu, JK Altman, H Sayar, BL Scott, ... Blood 138, 2601, 2021 | 11 | 2021 |
| Safety and efficacy of CPX-351 in younger patients< 60 years old with secondary acute myeloid leukemia: An updated analysis. AC Przespolewski, C Talati, S Fazal, P Vachhani, S Sanikommu, S Thota, ... Journal of Clinical Oncology 37 (15_suppl), e18530-e18530, 2019 | 6 | 2019 |
| Safety and efficacy of CPX-351 in younger patients (< 60 years old) with secondary acute myeloid leukemia A Przespolewski, AD Goldberg, C Talati, S Fazal, P Vachhani, ... Blood 141 (12), 1489-1493, 2023 | 5 | 2023 |
| Safety and efficacy of CPX-351 in younger patients< 60 years old with secondary acute myeloid leukemia: an updated analysis A Przespolewski, AD Goldberg, C Talati, S Fazal, P Vachhani, ... Blood 138, 1264, 2021 | 5 | 2021 |
| Financial toxicity intervention decreases mortality in high risk hematologic malignancy patients TG Knight, M Aguiar, M Robinson, A Martin, T Chen, R Bose, J Ai, ... Blood 136, 14-15, 2020 | 5* | 2020 |
| Ex vivo experiments show that IDH1/2-mutant inhibitors can be safely used as adjuvants to regular chemotherapy in IDH1/2-mutated acute myeloid leukemia R Molenaar, BJ Patel, M Khurshed, B Przychodzen, SR Sanikommu, ... Blood 126 (23), 3788, 2015 | 4 | 2015 |
| Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation SR Sanikommu, ES Reese, J He, C Lee, J Ai, CM Butler, R Jacobs, B Hu, ... Journal of Clinical Apheresis 36 (4), 553-562, 2021 | 3 | 2021 |
| Whole-exome sequencing identifies germline IDH2 and IDH3 mutations that predispose to myeloid neoplasms R Molenaar, SR Sanikommu, BJ Patel, B Przychodzen, CJ van Noorden, ... Blood 126 (23), 1405, 2015 | 3 | 2015 |
| Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF) AL Chojecki, KY DiSogra, J Arnall, N Cowgill, A Soni, CH Packman, ... Leukemia & Lymphoma 63 (6), 1515-1517, 2022 | 2 | 2022 |
| High frequency of subclonal myeloid mutations can be found in large granular lymphocyte leukemia E LeMelle, CM Hirsch, M Clemente, SR Sanikommu, V Adema, H Awada, ... Blood 130, 1171, 2017 | 2 | 2017 |
| Outcome of newly diagnosed acute myeloid leukemia (AML) refractory to 1 or 2 cycles of induction chemotherapy A Zarzour, A Nazha, M Kalaycio, BJ Patel, AT Gerds, MJ Clemente, ... Blood 126 (23), 1319, 2015 | 2 | 2015 |
